← Open Payments lookup

MICHELLE LEMON: Open Payments

NPI 1871631184 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$839 in 43 payments from 12 companies in 2025. Trend: 2023 $2,517 · 2024 $1,810 · 2025 $839

Food & beverage: $839
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc15$237
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$169
Teva Pharmaceuticals USA, Inc.4$92
Otsuka America Pharmaceutical, Inc.4$92
Collegium Pharmaceutical, Inc.4$79
Noven Therapeutics, LLC2$41
Axsome Therapeutics, Inc.2$35
VERTEX PHARMACEUTICALS INCORPORATED1$24
Alkermes, Inc.1$21
Neos Therapeutics, LP1$17

Products named: INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, Jornay PM, AUSTEDO XR, Xelstrym, Sunosi, VIVITROL.

Industry payments across NE — which companies pay providers there.